Resource utilization associated with initial hospital stays complicated by early onset group B streptococcal disease

Pediatric Infectious Disease Journal

Volumn 18, Issue 6, 1999, Pages 529-533

  Platt, Richard ^a,b   Adelson Mitty, Jennifer ^a   Weissman, Lynn ^a   Zaleznik, Dori ^a   Lee, Mei Ling ^a   Baker, Carol J ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Birth weight; Cost of illness; Group B Streptococcus; Hospitalization; Length of stay; Neonates

Indexed keywords

ARTICLE; CHEMOPROPHYLAXIS; FEMALE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; UNITED STATES;

COST OF ILLNESS; DISEASE TRANSMISSION, VERTICAL; FEMALE; HEALTH RESOURCES; HOSPITAL COSTS; HOSPITALIZATION; HUMANS; INFANT, NEWBORN; LENGTH OF STAY; MASSACHUSETTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RETROSPECTIVE STUDIES; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 0033002677     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199906000-00010     Document Type: Article

References (19)

1. Baker CJ, Edwards MS. Group B streptococcal infections. In: Remington JS, Klein JO, ed. Infectious diseases of the fetus and newborn infant. 4th ed. Philadelphia: Saunders, 1995: 980-1054.
2. Boyer KM, Gotoff SP. Prevention of early-onset group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med 1986;314:1665-9.
3. American Academy of Pediatrics, Committee on Infectious Diseases and Committee on Fetus and Newborn. Guidelines for prevention of group B streptococcal infection by chemoprophylaxis. Pediatrics 1992;90:775-8.
4. Centers for Disease Control and Prevention. Decreasing incidence of perinatal group B streptococcal disease: United States, 1993-1995. MMWR 1997;46:473-7.
5. Payne NR, Burke B, Day DL, Christenson PD, Thompson TR, Ferrieri, P. Correlation of clinical and pathologic findings in early-onset neonatal group B streptococcal infection with disease severity and prediction of outcome. Pediatr Infect Dis J 1988;7:836-7.
6. Schuchat A, Wenger JD. Epidemiology of group B streptococcal disease. Epidemiol Rev 1994;16:374-402.
7. Centers for Disease Control. Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR 1996;45(RR-7):1-24.
8. American College of Gynecology and Obstetrics. Prevention of early-onset group B streptococcal disease in newborns. ACOG Comm Opin 1996;173:1-8.
9. American Academy of Pediatrics; Committee on Infectious Diseases and Committee on Fetus and Newborn. Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. Pediatrics 1997;99:489-96.
10. Strickland DM, Yeomans, ER, Hankins, GD. Cost-effectiveness of intrapartum screening and treatment of maternal group B streptococci colonization. Am J Obstet Gynecol 1990;163:4-8.
11. Yancey MK, Duff P. An analysis of the cost-effectiveness of selected protocols for the prevention of neonatal group B streptococcal infection. Obstet Gynecol 1994;83:367-71.
12. Rouse DJ, Goldenberg RL, Cliver SP, Cutter GR, Mennemeyer ST, Fargason CA. Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: a decision analysis. Obstet Gynecol 1994;83:483-94.
13. Boyer KM. Maternal screening in prevention of neonatal infections: current status and rationale for group B streptococcal screening. J Hosp Infect 1988;11(Suppl A):328-33.
14. Garland SM, Kelly N. Early-onset neonatal group B streptococcal sepsis: economics of various prevention strategies. Med J Aust 1995;162:413-7.
15. Fargason CA, Peralta-Carcelen M, Rouse DJ, Cutter GR, Goldenberg RL. The pediatric costs of strategies for minimizing the risk of early-onset group B streptococcal disease. Obstet Gynecol 1997;90:347-52.
16. Mohle-Boetani JC, Schuchat A, Plikaytis BD, Smith D, Broome CV. Comparison of prevention strategies for neonatal group B streptococcal infection: a population-based analysis. JAMA 1993;270:1442-8.
17. Platt R, Stryker WS, Komaroff AL. Pharmacoepidemiology in hospitals using automated data systems. Am J Prev Med 1988; 4(Suppl):39-47.
18. Schwartz B, Schuchat A, Oxtoby MJ, Cochi SL, Hightower A, Broome CV. Invasive group B streptococcal disease in adults: a population-based study in metropolitan Atlanta. JAMA 1991;266:1112-4.
19. Faro S. Group B beta-hemolytic streptococci and puerperal infections. Am J Obstet Gynecol 1981;139:686-9.